Analyst Ratings for Moonlake Immunotherapeutics (MLTX)
MLTX Rating Summary
MLTX Price Target Summary
- Highest: $100.00 (H.C. Wainwright)
- Lowest: $59.00 (Barclays)
- Average: $72.77
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$72.77 (+71.5%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 88%
Rating Score: 8.6 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/2/2024 | Goldman Sachs | Richard Law | New Coverage | Neutral (N/A) |
62.00 (N/A) |
50.23 (42.43) |
-15.53% | Details |
| 2/15/2024 | Wolfe Research | Andy Chen | New Coverage | Outperform (N/A) |
77.00 (N/A) |
62.99 (42.43) |
-32.64% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
